Co-Authors
This is a "connection" page, showing publications co-authored by Katie Doores and Karen Bisnauthsing.
Connection Strength
0.566
-
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 12; 5(12):1598-1607.
Score: 0.227
-
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Dec; 26(12):1951.
Score: 0.057
-
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 Oct; 26(10):1663.
Score: 0.057
-
Translational Research in the Time of COVID-19-Dissolving Boundaries. PLoS Pathog. 2020 09; 16(9):e1008898.
Score: 0.057
-
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
Score: 0.057
-
A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020 10; 26(10):1623-1635.
Score: 0.056
-
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 Aug 21; 145(16):5638-5646.
Score: 0.056